Synopsis
Synopsis
0
KDMF
0
VMF
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. L 705,126
2. L 705126
3. L-705,126
4. L-705126
5. Maxalt
6. Mk 0462
7. Mk 462
8. Mk-0462
9. Mk-462
10. N,n-dimethyl-2-(5-(1,2,4-triazol-1-ylmethyl)-1h-indole-3-yl)ethylamine
11. Rizatriptan
1. 145202-66-0
2. Maxalt
3. Rizatriptan (benzoate)
4. Maxalt-mlt
5. Mk 462
6. Mk-462
7. Mk-0462
8. 2-(5-((1h-1,2,4-triazol-1-yl)methyl)-1h-indol-3-yl)-n,n-dimethylethanamine Benzoate
9. Nsc-758919
10. Wr978s7qhh
11. Rizatriptan Benzoate (maxalt)
12. N,n-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1h-indol-3-yl]ethylamine Benzoate
13. 3-(2-(dimethylamino)ethyl)-5-(1h-1,2,4-triazol-1-ylmethyl)indole Monobenzoate
14. 1h-indole-3-ethanamine, N,n-dimethyl-5-(1h-1,2,4-triazol-1-ylmethyl)-, Monobenzoate
15. 2-(5-((1h-1,2,4-triazol-1-yl)methyl)-1h-indol-3-yl)-n,n-dimethylethan-1-amine Benzoate
16. Benzoic Acid;n,n-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1h-indol-3-yl]ethanamine
17. Rizatriptanbenzoate
18. N,n-dimethyl-5-(1h-1,2,4-triazol-1-ylmethyl)-1h-indole-3-ethanamine Benzoate
19. Rizatriptan Benzoate [usan]
20. Mk 0462
21. Unii-wr978s7qhh
22. L 705126
23. L 705,126
24. L-705,126
25. Rizatriptan Benzoate [usan:usp]
26. Rizatrimptan Benzoate
27. Rizatriptane Benzoate
28. Rizatriptan, Benzoate
29. Mk-462 Benzoate
30. Schembl41226
31. Mls001424197
32. Chebi:8875
33. Rizatriptan Benzoate Salt
34. Chembl1201032
35. Rizatriptan Benzoate (jan/usp)
36. Amy8935
37. Dtxsid20162937
38. Rhb-103
39. Rizatriptan Benzoate [mi]
40. Hms2051b16
41. Hms2093k08
42. Hms2235m18
43. Hms3369i15
44. Hms3393b16
45. Hms3655k09
46. Hms3715d08
47. Hms3884k21
48. Pharmakon1600-01505189
49. Rizatriptan Benzoate [jan]
50. Act04340
51. Bcp02149
52. Hy-b0206
53. Int-0008
54. Rizatriptan Benzoate [vandf]
55. Ac-734
56. Mfcd00866224
57. Nsc758919
58. Rizatriptan Benzoate [mart.]
59. Rizatriptan Benzoate [usp-rs]
60. Rizatriptan Benzoate [who-dd]
61. Akos015855933
62. Ab07521
63. Ccg-101039
64. Ks-1189
65. Nc00289
66. Nsc 758919
67. Rizatriptan Benzoate [orange Book]
68. Smr000525252
69. Rizatriptan Benzoate [ep Monograph]
70. Db-015783
71. Rizatriptan Benzoate [usp Monograph]
72. Rizatriptan Benzoate Salt, >=98% (hplc)
73. Ft-0631171
74. R0107
75. R0181
76. S1607
77. Sw197669-2
78. D00675
79. 202r660
80. A808337
81. Sr-01000763588
82. J-008071
83. J-524222
84. Sr-01000763588-3
85. Q27292788
86. Rizatriptan Benzoate, European Pharmacopoeia (ep) Reference Standard
87. Rizatriptan Benzoate, United States Pharmacopeia (usp) Reference Standard
88. Dimethyl-[2-(5-[1,2,4]triazol-1-ylmethyl-1h-indol-3-yl)-ethyl]-amine Benzoate
89. N,n-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1h-indol-3-yl]ethanamine Benzoate
90. Rizatriptan For System Suitability, European Pharmacopoeia (ep) Reference Standard
Molecular Weight | 391.5 g/mol |
---|---|
Molecular Formula | C22H25N5O2 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 6 |
Exact Mass | 391.20082506 g/mol |
Monoisotopic Mass | 391.20082506 g/mol |
Topological Polar Surface Area | 87 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 412 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Maxalt |
PubMed Health | Rizatriptan (By mouth) |
Drug Classes | Antimigraine |
Drug Label | MAXALTCOPYRIGHT 1998, 2006 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.All rights reserved contains rizatriptan benzoate, a selective 5-hydroxytryptamine1B/1D (5-HT1B/1D) receptor agonist.Rizatriptan benzoate is described chemical |
Active Ingredient | Rizatriptan benzoate |
Dosage Form | Tablet |
Route | Oral |
Strength | eq 5mg base; eq 10mg base |
Market Status | Prescription |
Company | Merck |
2 of 4 | |
---|---|
Drug Name | Rizatriptan benzoate |
Drug Label | MAXALTCOPYRIGHT 1998, 2006 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.All rights reserved contains rizatriptan benzoate, a selective 5-hydroxytryptamine1B/1D (5-HT1B/1D) receptor agonist.Rizatriptan benzoate is described chemical |
Active Ingredient | Rizatriptan benzoate |
Dosage Form | Tablet; Tablet, orally disintegrating |
Route | Oral |
Strength | eq 5mg base; eq 10mg base |
Market Status | Prescription |
Company | Mylan Pharms; Apotex; Aurobindo Pharma; Natco Pharma; Sandoz; Invagen Pharms; Cipla; Sun Pharma Global; Glenmark Generics; Emcure Pharms; Teva Pharms; Macleods Pharms |
3 of 4 | |
---|---|
Drug Name | Maxalt |
PubMed Health | Rizatriptan (By mouth) |
Drug Classes | Antimigraine |
Drug Label | MAXALTCOPYRIGHT 1998, 2006 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.All rights reserved contains rizatriptan benzoate, a selective 5-hydroxytryptamine1B/1D (5-HT1B/1D) receptor agonist.Rizatriptan benzoate is described chemical |
Active Ingredient | Rizatriptan benzoate |
Dosage Form | Tablet |
Route | Oral |
Strength | eq 5mg base; eq 10mg base |
Market Status | Prescription |
Company | Merck |
4 of 4 | |
---|---|
Drug Name | Rizatriptan benzoate |
Drug Label | MAXALTCOPYRIGHT 1998, 2006 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.All rights reserved contains rizatriptan benzoate, a selective 5-hydroxytryptamine1B/1D (5-HT1B/1D) receptor agonist.Rizatriptan benzoate is described chemical |
Active Ingredient | Rizatriptan benzoate |
Dosage Form | Tablet; Tablet, orally disintegrating |
Route | Oral |
Strength | eq 5mg base; eq 10mg base |
Market Status | Prescription |
Company | Mylan Pharms; Apotex; Aurobindo Pharma; Natco Pharma; Sandoz; Invagen Pharms; Cipla; Sun Pharma Global; Glenmark Generics; Emcure Pharms; Teva Pharms; Macleods Pharms |
Serotonin Receptor Agonists
Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. (See all compounds classified as Serotonin Receptor Agonists.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
A Rizatriptan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rizatriptan, including repackagers and relabelers. The FDA regulates Rizatriptan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rizatriptan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Rizatriptan manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Rizatriptan supplier is an individual or a company that provides Rizatriptan active pharmaceutical ingredient (API) or Rizatriptan finished formulations upon request. The Rizatriptan suppliers may include Rizatriptan API manufacturers, exporters, distributors and traders.
click here to find a list of Rizatriptan suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Rizatriptan DMF (Drug Master File) is a document detailing the whole manufacturing process of Rizatriptan active pharmaceutical ingredient (API) in detail. Different forms of Rizatriptan DMFs exist exist since differing nations have different regulations, such as Rizatriptan USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Rizatriptan DMF submitted to regulatory agencies in the US is known as a USDMF. Rizatriptan USDMF includes data on Rizatriptan's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Rizatriptan USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Rizatriptan suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Rizatriptan Drug Master File in Japan (Rizatriptan JDMF) empowers Rizatriptan API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Rizatriptan JDMF during the approval evaluation for pharmaceutical products. At the time of Rizatriptan JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Rizatriptan suppliers with JDMF on PharmaCompass.
A Rizatriptan CEP of the European Pharmacopoeia monograph is often referred to as a Rizatriptan Certificate of Suitability (COS). The purpose of a Rizatriptan CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Rizatriptan EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Rizatriptan to their clients by showing that a Rizatriptan CEP has been issued for it. The manufacturer submits a Rizatriptan CEP (COS) as part of the market authorization procedure, and it takes on the role of a Rizatriptan CEP holder for the record. Additionally, the data presented in the Rizatriptan CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Rizatriptan DMF.
A Rizatriptan CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Rizatriptan CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Rizatriptan suppliers with CEP (COS) on PharmaCompass.
A Rizatriptan written confirmation (Rizatriptan WC) is an official document issued by a regulatory agency to a Rizatriptan manufacturer, verifying that the manufacturing facility of a Rizatriptan active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Rizatriptan APIs or Rizatriptan finished pharmaceutical products to another nation, regulatory agencies frequently require a Rizatriptan WC (written confirmation) as part of the regulatory process.
click here to find a list of Rizatriptan suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Rizatriptan as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Rizatriptan API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Rizatriptan as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Rizatriptan and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Rizatriptan NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Rizatriptan suppliers with NDC on PharmaCompass.
Rizatriptan Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Rizatriptan GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Rizatriptan GMP manufacturer or Rizatriptan GMP API supplier for your needs.
A Rizatriptan CoA (Certificate of Analysis) is a formal document that attests to Rizatriptan's compliance with Rizatriptan specifications and serves as a tool for batch-level quality control.
Rizatriptan CoA mostly includes findings from lab analyses of a specific batch. For each Rizatriptan CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Rizatriptan may be tested according to a variety of international standards, such as European Pharmacopoeia (Rizatriptan EP), Rizatriptan JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Rizatriptan USP).
LOOKING FOR A SUPPLIER?